The company has informed that the Board of Directors of the Company in its meeting held on 28 July 2026 approved the formation of a new subsidiary company under the title of "ACI Global Scientific Standards Limited" having an authorized capital of BDT 50 (Fifty) Crore and a paid up capital of BDT 3 (Three) Crore wherein Advanced Chemical Industries PLC shall hold 85% shares, subject to the approval of the concerned authorities.

The Board of Directors of the Company, at its 230th Board meeting held on 14 July 2026 has approved an investment of BDT 700 Crore in ACI Logistics Limited, a subsidiary of the Company. The investment will be made through the subscription of 7,000,000 (Seven Million) Convertible Preference Shares of BDT 1,000/- (BDT One Thousand) each, to be issued by ACI Logistics Limited. The investment will be made on or before 15 October 2026, subject to the approval of the concerned authorities.

The company has informed that the Board of Directors of the Company in its meeting held on 29 April 2026 approved the formation of a joint-venture company under the title of "Deli ACI Bangladesh Limited" having an authorized capital of BDT 100 (One Hundred) Crore and a paid up capital of BDT 27 (Twenty-Seven) Crore wherein Advanced Chemical Industries PLC shall hold 50% shares, subject to the approval of the concerned authority.

(Continuation news of ACI): On the other hand, cost of borrowing increased due to additional funding for working capital and strategic investments for supporting business growth. Overall, the consolidated EPS was Taka (4.18) during the period against Taka (9.11) of SPLY. NOCFPS during the period was Taka (68.02) against Taka (83.14) as a result of the movement in the working capital. (end)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.

Dr. Arif Dowla, Managing Director of the company, has further informed that he has completed his buying of 302,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated on 09.04.2026.

Dr. Arif Dowla, Managing Director of the company, has expressed his intention to buy 302,000 shares of the company at prevailing market price (in the Block Market) through Dhaka Stock Exchange PLC. within April 30, 2026 pursuant to the Regulation 34(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, as well as Rule 4 of the BSEC (Ullekhzogyo Sonkhyok Share Orjon, Odhigrohon o Kortritto Grohon) Bidhimala, 2018.

(Cont. News of ACI): On the other hand, cost of borrowing increased due to the increase of interest rate along with the additional funding for working capital and strategic investments for supporting business growth. Overall, the consolidated EPS was Taka 0.73 during the period against Taka (7.99) of SPLY. NOCFPS during the period was Taka (50.50) against Taka (63.60) as a result of the movement in the working capital. (end)

The company has informed that the Board of Directors of the Company, at its meeting held on 29 January 2026 approved the formation and establishment of an institution under the name and title "ACI Institution of Artificial Intelligence" with an initial investment of BDT 5 (Five) Crore, subject to the approval of the concerned authorities.

(Cont. News of ACI): The investment will be made on or before 31 March 2026, subject to the approval of the concerned authorities. (end)